Status: Recruiting
Safety and Potential Effect of Innovative Treatment by Adjuvant Injection of Stromal Vascular Fraction From Autologous Adipose Tissue of URethral Stenosis With Endoscopic Urethrotomy
SURF is a randomised controlled, parallel group, single blind phase II study designed to assess the safety and potential efficacy of an innovative therapeutic strategy for urethral stenosis based on adjuvant injection of autologous Adipose-Derived Stromal Vascular Fraction of Adipose Tissue (ADSVF) during endoscopic urethrotomy (standard care).
Participants needed: 20
Trial details
Phase: Phase 2Age: 18-85Biological sex: MaleType: InterventionalSponsor: Assistance Publique Hopitaux De MarseilleUpdated: Feb 4, 2026Locations: 1
Eligibility criteria
Signed informed consent [+6]
Urethral stenosis of other location than bulbar [+15]